APO-Metaraminol metaraminol (as tartrate) 10 mg/1 mL solution for injection ampoule

Land: Australia

Språk: engelsk

Kilde: Department of Health (Therapeutic Goods Administration)

Aktiv ingrediens:

metaraminol tartrate, Quantity: 18.976 mg (Equivalent: metaraminol, Qty 10 mg)

Tilgjengelig fra:

Arrotex Pharmaceuticals Pty Ltd

Legemiddelform:

Injection, solution

Sammensetning:

Excipient Ingredients: sodium metabisulfite; water for injections; sodium chloride

Administreringsrute:

Intravenous

Enheter i pakken:

5

Resept typen:

(S4) Prescription Only Medicine

Indikasjoner:

Prevention and treatment of the acute hypotensive state occurring with spinal anaesthesia; adjunctive treatment of hypotension due to haemorrhage, reactions to medications, surgical complications, and shock associated with brain damage due to tumour or trauma.,It may also be useful as an adjunct in the treatment of hypotension due to cardiogenic shock or septicaemia.

Produkt oppsummering:

Visual Identification: clear colorless solution; Container Type: Ampoule; Container Material: Glass; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

Autorisasjon status:

Registered

Autorisasjon dato:

2019-09-26